{"componentChunkName":"component---node-modules-gatsby-theme-buzzing-src-gatsby-theme-blog-core-templates-post-query-js","path":"/en/reddit/r/stocks/comments/n14tdv/palantirs_new_joint_venture_looks_to_tear_down/","result":{"data":{"site":{"siteMetadata":{"title":"国外股市热门","description":"用中文浏览国外股票社区里的热门讨论","social":[{"name":"Reddit Stocks","url":"https://www.reddit.com/r/stocks","external":true,"prefetch":null},{"name":"Reddit Investing","url":"https://www.reddit.com/r/investing","external":true,"prefetch":null},{"name":"Reddit Bogleheads","url":"https://www.reddit.com/r/Bogleheads/","external":true,"prefetch":null},{"name":"Buzzing","url":"https://www.buzzing.cc/","external":true,"prefetch":null}],"menuLinks":[{"name":"每周精选","url":"/issues","external":null,"prefetch":null}],"localize":[{"title":"Buzzing on Stocks","description":"See popular discussions in foreign stock communities in your native language","locale":"en","social":[{"name":"Reddit","url":"https://www.reddit.com/","external":true,"prefetch":null}],"menuLinks":[{"name":"Weekly Selection","url":"/en/issues","external":null,"prefetch":null}]},{"title":"國外股市熱門","description":"用中文瀏覽國外股票社區裡的熱門討論","locale":"zh-Hant","social":null,"menuLinks":[{"name":"每週精選","url":"/zh-Hant/issues","external":null,"prefetch":null}]},{"title":"米国株式市場人気の話し合います","description":"人気の米国株式市場の話し合いまを日本語で閲覧","locale":"ja","social":null,"menuLinks":[{"name":"每週精選","url":"/ja/issues","external":null,"prefetch":null}]}]}},"blogPost":{"__typename":"SocialMediaPost","id":"RedditPost-n14tdv","excerpt":"https://twitter.com/PalantirTech/status/1387764219060293649?s=20\n\n7:42 AM - Apr 29, 2021\n\nBoston-based Syntropy will create a digital platform that allows cancer\nresearchers to share and analyze data from numerous different organizations.\n\nMerck KGaA, Darmstadt, and Silicon Valley-area big data…","body":"<!-- SC_OFF --><div class=\"md\"><p><a href=\"https://twitter.com/PalantirTech/status/1387764219060293649?s=20\">https://twitter.com/PalantirTech/status/1387764219060293649?s=20</a></p>\n\n<p>7:42 AM - Apr 29, 2021</p>\n\n<p>Boston-based Syntropy will create a digital platform that allows cancer researchers to share and analyze data from numerous different organizations.</p>\n\n<p>Merck KGaA, Darmstadt, and Silicon Valley-area big data company Palantir Technologies announced a joint venture that will focus on building an analytics and collaborative technology platform for cancer researchers.</p>\n\n<p>Called Syntropy, the Boston-based effort will rely on Palantir Foundry to power its data integration platform. Any research data shared across participating groups will be transparent and secure, according to the companies, with the participating institutions maintaining ownership of their data.</p>\n\n<p>&quot;Unlocking the power of scientific data is critical to advancing the fight against cancer,&quot; Alexander Karp, Palantir cofounder and CEO, said in a statement. &quot;Syntropy aims to help researchers collaborate securely to realize the value of this data, driving discoveries that will deliver better treatments to patients faster.”</p>\n\n<p>Why it matters</p>\n\n<p>Numerous hospitals and research institutions are actively conducting cancer research, but the data they are generating is often limited to their own organization. Syntropy’s collaborative platform would looks to be a collective ecosystem that houses these research data and facilitates cross-institution analyses to drive new breakthroughs in cancer research and care.</p>\n</div><!-- SC_ON -->","slug":"/reddit/r/stocks/comments/n14tdv/palantirs_new_joint_venture_looks_to_tear_down/","title":"Palantir's new joint venture looks to tear down cancer research data silos","tags":["stocks","reddit"],"date":"April 29, 2021","dateISO":"2021-04-29T15:29:17.000Z","datetime":"2021-04-29 15:29","image":null,"imageAlt":null,"socialImage":null,"fields":{"basePath":"/"},"thirdPartyId":"n14tdv","provider":"Reddit","url":"https://www.reddit.com/r/stocks/comments/n14tdv/palantirs_new_joint_venture_looks_to_tear_down/","originalUrl":"https://www.reddit.com/r/stocks/comments/n14tdv/palantirs_new_joint_venture_looks_to_tear_down/","imageRemote":null,"video":null,"channel":"stocks","channelUrl":"https://www.reddit.com/r/stocks","author":"NineteenSixtySix","authorUrl":"https://www.reddit.com/user/NineteenSixtySix","authorImage":null,"authorSlug":"NineteenSixtySix","score":1967,"views":null,"sharedCount":null,"likeCount":null,"sharedContent":null,"parent":{"__typename":"RedditJson","localize":[{"title":"パランティアの新しいジョイントベンチャーは、がん研究のデータサイロを破壊することを目指しています。","the_new_excerpt":"https://twitter.com/PalantirTech/status/1387764219060293649?s=20\n\n午前7時42分 - 2021年4月29日\n\nボストンを拠点とするSyntropy社は、がん研究者が様々な組織のデータを共有し、分析するためのデジタルプラットフォームを構築します。\n癌研究者が多数の異なる組織からのデータを共有・分析できるデジタルプラットフォームを構築します。\n\nMerck KGaA（ダルムシュタット）とシリコンバレー地域のビッグデータ...","locale":"ja"},{"title":"Palantir公司的新合资企业希望打破癌症研究的数据孤岛","the_new_excerpt":"https://twitter.com/PalantirTech/status/1387764219060293649?s=20\n\n7:42 AM - 2021年4月29日\n\n总部位于波士顿的Syntropy公司将创建一个数字平台，使癌症研究人员能够分享和分析来自许多不同组织的数据。\n研究人员分享和分析来自许多不同组织的数据。\n\n位于达姆施塔特的默克公司和硅谷地区的大数据...","locale":"zh"},{"title":"Palantir公司的新合資企業希望打破癌症研究的數據孤島","the_new_excerpt":"https://twitter.com/PalantirTech/status/1387764219060293649?s=20\n\n7:42 AM - 2021年4月29日\n\n總部位於波士頓的Syntropy公司將創建一個數字平臺，使癌症研究人員能夠分享和分析來自許多不同組織的數據。\n研究人員分享和分析來自許多不同組織的數據。\n\n位於達姆施塔特的默克公司和硅谷地區的大數據...","locale":"zh-Hant"}]}},"previous":{"id":"RedditPost-n13hwg","excerpt":"Welcome to Part I of my Pharma Stocks Guide. I see a lot of interest in\npharmaceuticals and my goal is to provide people with a little more information\nso they can make an informed decision. Today's topic will be: The FDA Drug\nApproval Process\n\nThe FDA Drug Approval Process can be broken down into 4…","slug":"/reddit/r/stocks/comments/n13hwg/basic_overview_of_the_fda_drug_approval_process/","title":"Basic Overview of the FDA Drug Approval Process","date":"April 29, 2021","__typename":"SocialMediaPost","parent":{"__typename":"RedditJson","localize":[{"title":"FDA医薬品承認プロセスの基本概要","the_new_excerpt":"私の医薬品株ガイドのパート1にようこそ。製薬会社には多くの関心が寄せられています。\n私の目標は、皆さんに少しでも多くの情報を提供して、投資判断をしていただくことです。\n私の目標は、皆さんに少しでも多くの情報を提供し、十分な情報に基づいた決断をしていただくことです。今日のトピックは FDAの医薬品\n承認プロセス\n\nFDAの医薬品承認プロセスは、以下の4つに分けられます。","locale":"ja"},{"title":"美国食品和药物管理局药品审批程序的基本概述","the_new_excerpt":"欢迎来到我的医药股指南的第一部分。我看到很多人对\n我的目标是为人们提供更多的信息\n这样他们就可以做出一个明智的决定。今天的主题将是。美国食品和药物管理局的药物\n审批程序\n\n美国食品和药物管理局（FDA）的药品审批程序可以分为4个部分...","locale":"zh"},{"title":"美國食品和藥物管理局藥品審批程序的基本概述","the_new_excerpt":"歡迎來到我的醫藥股指南的第一部分。我看到很多人對\n我的目標是爲人們提供更多的信息\n這樣他們就可以做出一個明智的決定。今天的主題將是。美國食品和藥物管理局的藥物\n審批程序\n\n美國食品和藥物管理局（FDA）的藥品審批程序可以分爲4個部分...","locale":"zh-Hant"}]}},"next":{"id":"TweetPost-1387775816289984525","excerpt":"","slug":"/tweet/1387775816289984525","title":"The price of Lumber is 5x higher than it was 10 years ago.\n\nFed: \"Ignore, Just Transitory.\" https://t.co/ffR2CKvvQZ","__typename":"SocialMediaPost","date":"April 29, 2021","parent":{"__typename":"TweetJson","localize":[{"locale":"ja","full_text":"材木の価格は10年前の5倍に。\n\nFRBです。\"Ignore, Just Transitory.\" https://t.co/ffR2CKvvQZ","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh","full_text":"木材的价格比10年前高出5倍。\n\n美联储。\"不要理会，只是过渡性的。\" https://t.co/ffR2CKvvQZ","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh-Hant","full_text":"木材的價格比10年前高出5倍。\n\n美聯儲。\"不要理會，只是過渡性的。\" https://t.co/ffR2CKvvQZ","quoted_status_full_text":null,"retweeted_status_full_text":null}]}}},"pageContext":{"id":"RedditPost-n14tdv","previousId":"RedditPost-n13hwg","nextId":"TweetPost-1387775816289984525","maxWidth":1024,"locale":"en","hrefLang":"en-US","originalPath":"/reddit/r/stocks/comments/n14tdv/palantirs_new_joint_venture_looks_to_tear_down/","dateFormat":"MM/DD/YYYY"}},"staticQueryHashes":["1239077767","2506312863","2744905544","3493603132","3493603132","3513215887","386998304"]}